ADHD assessment
Mechanistic Hypotheses (Research-Only Context) Though unproven in humans, AOD-9604 continues to attract scientific curiosity as a model peptide for studying metabolic regulation
Participants were randomized 2:1:1:1:1:2:2 to receive placebo or retatrutide at 1 mg, 4 mg (starting at 2 mg), 4 mg (starting at 4 mg), 8 mg (starting at 2 mg), 8 mg (starting at 4 mg), or 12 mg (starting at 2 mg) administered subcutaneously once weekly for 48 weeks
Current expectations point to FDA review and potential approval in the 2027 to 2028 range
Whichever path you take: always ask for a COA (Certificate of Analysis - the lab report that verifies the product contains what it claims, at the right dose)
Therefore, we do not claim direct causality between an individuals prior B12 test and their hospitalization episode, although a significant correlation exists in large populational level between vitamin B 12 deficiency and hospital admissions for cardiovascular, hematological, neurological, psychological, and gastrointestinal diseases